BM

Bibhas Mondal

Active Director Director DIN 09267513
DIN 09267513 First appointment Aug 2021 Primary industry Non-Profit Organizations
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Bibhas Mondal

Data last updated:

Bibhas Mondal is a Director at Rani Shiromoni Institute Of Medical Sciences And Research Private Limited (since 2021). The company operates in Non-Profit Organizations.

DIN 09267513
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 04 Aug 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Aug 20212021Active

Directorship timeline

Open interactive timeline →
Rani Shiromoni Institute Of Medical Sciences And Research Private Limited
Premium access

Shareholding and investment profile for Bibhas Mondal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bibhas Mondal

Bibhas Mondal currently holds 1 directorship: Rani Shiromoni Institute Of Medical Sciences And Research Private Limited (Director, since 04 Aug 2021).

Bibhas Mondal was first appointed on 04 Aug 2021 as Director at Rani Shiromoni Institute Of Medical Sciences And Research Private Limited.

The current boards of Bibhas Mondal's companies include Gourhari Patra (Rani Shiromoni Institute Of Medical Sciences And Research Private Limited), Pranab Das (Rani Shiromoni Institute Of Medical Sciences And Research Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available